Loudon Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.02M | Sell |
19,952
-275
| -1% | -$59.2K | 2.46% | 12 |
|
|
2026
Q1 | $4.4M | Sell |
20,227
-475
| -2% | -$105K | 2.37% | 14 |
|
|
2025
Q4 | $4.73M | Sell |
20,702
-100
| -0.5% | -$22.8K | 2.47% | 12 |
|
|
2025
Q3 | $4.82M | Sell |
20,802
-135
| -0.6% | -$27.5K | 2.52% | 13 |
|
|
2025
Q2 | $3.89M | Sell |
20,937
-500
| -2% | -$92.9K | 2.15% | 13 |
|
|
2025
Q1 | $4.49M | Sell |
21,437
-302
| -1% | -$58.7K | 2.57% | 12 |
|
|
2024
Q4 | $3.86M | Sell |
21,739
-300
| -1% | -$55.2K | 2.2% | 17 |
|
|
2024
Q3 | $4.35M | Sell |
22,039
-930
| -4% | -$174K | 2.39% | 16 |
|
|
2024
Q2 | $3.94M | Hold |
22,969
| – | – | 2.32% | 14 |
|
|
2024
Q1 | $4.18M | Sell |
22,969
-1,724
| -7% | -$297K | 2.4% | 13 |
|
|
2023
Q4 | $3.83M | Sell |
24,693
-758
| -3% | -$111K | 2.37% | 15 |
|
|
2023
Q3 | $3.79M | Sell |
25,451
-286
| -1% | -$42K | 2.61% | 12 |
|
|
2023
Q2 | $3.47M | Sell |
25,737
-1,640
| -6% | -$240K | 2.29% | 13 |
|
|
2023
Q1 | $4.36M | Sell |
27,377
-2,623
| -9% | -$401K | 3.02% | 8 |
|
|
2022
Q4 | $4.85M | Sell |
30,000
-1,929
| -6% | -$296K | 3.5% | 3 |
|
|
2022
Q3 | $4.29M | Sell |
31,929
-11,383
| -26% | -$1.63M | 3.41% | 5 |
|
|
2022
Q2 | $6.63M | Sell |
43,312
-5,198
| -11% | -$794K | 4.97% | 2 |
|
|
2022
Q1 | $7.86M | Sell |
48,510
-1,555
| -3% | -$226K | 5.18% | 2 |
|
|
2021
Q4 | $6.78M | Sell |
50,065
-640
| -1% | -$75.6K | 4.33% | 3 |
|
|
2021
Q3 | $5.47M | Sell |
50,705
-543
| -1% | -$62K | 3.89% | 3 |
|
|
2021
Q2 | $5.77M | Sell |
51,248
-9
| -0% | -$1.01K | 3.94% | 4 |
|
|
2021
Q1 | $5.55M | Buy |
51,257
+185
| +0.4% | +$19.8K | 3.98% | 3 |
|
|
2020
Q4 | $5.47M | Sell |
51,072
-1,405
| -3% | -$135K | 4.28% | 3 |
|
|
2020
Q3 | $4.6M | Sell |
52,477
-2,422
| -4% | -$228K | 3.89% | 6 |
|
|
2020
Q2 | $5.39M | Buy |
54,899
+50
| +0.1% | +$4.4K | 4.65% | 3 |
|
|
2020
Q1 | $4.18M | Buy |
54,849
+1,100
| +2% | +$93.7K | 4.37% | 4 |
|
|
2019
Q4 | $4.76M | Buy |
53,749
+465
| +0.9% | +$38.6K | 3.71% | 5 |
|
|
2019
Q3 | $4.04M | Buy |
53,284
+165
| +0.3% | +$11.3K | 3.4% | 6 |
|
|
2019
Q2 | $3.86M | Buy |
53,119
+12,570
| +31% | +$988K | 3.28% | 6 |
|
|
2019
Q1 | $3.27M | Buy |
40,549
+4,145
| +11% | +$339K | 2.87% | 10 |
|
|
2018
Q4 | $3.36M | Buy |
36,404
+9,771
| +37% | +$859K | 3.19% | 6 |
|
|
2018
Q3 | $2.52M | Sell |
26,633
-95
| -0.4% | -$9.01K | 2.03% | 18 |
|
|
2018
Q2 | $2.48M | Sell |
26,728
-1,796
| -6% | -$175K | 1.98% | 20 |
|
|
2018
Q1 | $2.7M | Sell |
28,524
-3,865
| -12% | -$425K | 2.15% | 16 |
|
|
2017
Q4 | $3.13M | Sell |
32,389
-1,265
| -4% | -$119K | 2.37% | 11 |
|
|
2017
Q3 | $2.99M | Sell |
33,654
-900
| -3% | -$68.5K | 2.34% | 15 |
|
|
2017
Q2 | $2.51M | Sell |
34,554
-150
| -0.4% | -$10.1K | 1.9% | 21 |
|
|
2017
Q1 | $2.26M | Sell |
34,704
-1,640
| -5% | -$103K | 1.72% | 23 |
|
|
2016
Q4 | $2.28M | Buy |
36,344
+85
| +0.2% | +$5.19K | 1.78% | 25 |
|
|
2016
Q3 | $2.29M | Sell |
36,259
-425
| -1% | -$27.5K | 1.78% | 24 |
|
|
2016
Q2 | $2.27M | Buy |
36,684
+3,100
| +9% | +$189K | 1.81% | 23 |
|
|
2016
Q1 | $1.92M | Sell |
33,584
-2,184
| -6% | -$122K | 1.54% | 23 |
|
|
2015
Q4 | $2.12M | Hold |
35,768
| – | – | 1.7% | 21 |
|
|
2015
Q3 | $1.95M | Sell |
35,768
-161
| -0.4% | -$10.5K | 1.67% | 24 |
|
|
2015
Q2 | $2.41M | Sell |
35,929
-225
| -0.6% | -$14.7K | 1.83% | 23 |
|
|
2015
Q1 | $2.12M | Sell |
36,154
-77
| -0.2% | -$4.65K | 1.6% | 21 |
|
|
2014
Q4 | $2.37M | Sell |
36,231
-450
| -1% | -$28.4K | 1.77% | 19 |
|
|
2014
Q3 | $2.12M | Sell |
36,681
-800
| -2% | -$44.4K | 1.51% | 22 |
|
|
2014
Q2 | $2.12M | Sell |
37,481
-5,200
| -12% | -$273K | 1.45% | 23 |
|
|
2014
Q1 | $2.19M | Sell |
42,681
-8,015
| -16% | -$405K | 1.58% | 20 |
|
|
2013
Q4 | $2.68M | Buy |
+50,696
| New | +$2.49M | 1.96% | 18 |
|
Other funds holding ABBV
Loudon Investment Management's ABBV Position: Q2 2026 in Review
Loudon Investment Management reduced its AbbVie (ABBV) stake by 1.4% in Q2 2026, selling an estimated $59.2K and leaving 19,952 shares worth $5.02M. The position accounts for 2.46% of the portfolio, ranked #12.
Loudon Investment Management first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. The position peaked at $7.86M in Q1 2022. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Loudon Investment Management held 19,952 shares of AbbVie worth $5.02M as of Q2 2026.
- Loudon Investment Management sold 275 AbbVie shares in Q2 2026, an estimated $59.2K.
- AbbVie made up 2.46% of Loudon Investment Management's portfolio in Q2 2026, its #12 holding.
- Loudon Investment Management first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- Loudon Investment Management's AbbVie position peaked at $7.86M in Q1 2022.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Loudon Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.